The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion - comprised of preeminent global health experts - to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.
Panelists will provide their unique perspectives on:
- How do these partnerships find success in the face of seemingly insurmountable challenges?
- What have we learned from past successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
- Where are the opportunities for the next big solutions?
- Who is missing from the table in the effort to push back against HIV, TB, malaria and neglected tropical diseases?
- Why should those outside the global health and NGO worlds join this effort?
The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.
November 12, 2013
- Peter Piot, M.D., Ph.D.
Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member
- Ann M. Veneman, J.D.
Former Executive Director of UNICEF; Former Secretary of Agriculture; GHIT Fund Board Member
- Mel Spigelman, M.D.
President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee
- Kiyoshi Kurokawa, M.D.
Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute
- Ko-Yung Tung, J.D.
Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor
333 East 47th Street
New York, NY 10017
About the Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund is a non-profit organization aimed at mobilizing Japanese R&D for global health. A public-private partnership between the Government of Japan, a consortium of Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation, the GHIT Fund seeks to develop new drugs, vaccines and diagnostics for infectious diseases prevalent in developing countries. More information is available at http://www.